News
Hardman & Co Research : Pantheon International Plc (PIN): FY’22 results: it is not just lionesses that roar
Hardman & Co Research : Pantheon International Plc (PIN): FY’22 results: it is not just lionesses that roar
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
DGAP-News: Baader Bank increases share capital as part of scrip dividend
DGAP-News: Baader Bank increases share capital as part of scrip dividend
DGAP-News: Medios AG continues record course: Strong growth in the first half of 2022
DGAP-News: Medios AG continues record course: Strong growth in the first half of 2022
DGAP-News: AURELIUS Equity Opportunities reports robust growth also in the first half of 2022 despite persistently tough economic conditions
DGAP-News: AURELIUS Equity Opportunities reports robust growth also in the first half of 2022 despite persistently tough economic conditions
Presentation of HIAG's half-year results 2022 on 26 August 2022
Presentation of HIAG's half-year results 2022 on 26 August 2022
DGAP-News: ProCredit Holding AG & Co. KGaA: ProCredit group reports positive half-year result; efficiency gains across the group balance substantial provisions for Ukrainian operations
DGAP-News: ProCredit Holding AG & Co. KGaA: ProCredit group reports positive half-year result; efficiency gains across the group balance substantial provisions for Ukrainian operations
Victory Capital Reports July 2022 Assets Under Management
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today reported assets under management (AUM) of $164.2 billion as of July 31, 2022. The Company also reported
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Partners Group to expand the shareholder base of USIC, the leading North American provider of utility location services; Kohlberg & Company to acquire a 50% stake
Partners Group to expand the shareholder base of USIC, the leading North American provider of utility location services; Kohlberg & Company to acquire a 50% stake
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Custodian REIT plc : Director’s purchase of ordinary shares
Custodian REIT plc : Director’s purchase of ordinary shares
Arix Bioscience plc Announces Changes to Board of Directors
Arix Bioscience plc Announces Changes to Board of Directors
Interim Results for the Six Months Ended 30 June 2022
Interim Results for the Six Months Ended 30 June 2022